Selected article for: "cc ND international license and general population"
Author: Nicholas Gray; Dominic Calleja; Alex Wimbush; Enrique Miralles-Dolz; Ander Gray; Marco De-Angelis; Elfride Derrer-Merk; Bright Uchenna Oparaji; Vladimir Stepanov; Louis Clearkin; Scott Ferson
Title: No test is better than a bad test"": Impact of diagnostic uncertainty in mass testing on the spread of Covid-19
  • Document date: 2020_4_22
    • ID: 2jwuzfan_49
    Snippet: To simulate the prevalence of antibodies in the general population the model is preconditioned with different proportions of the population in the Q S and Q R states. This is analogous to the proportion of people that are currently in quarantine who have either had the virus and developed some immunity, and the proportion of the population who have not contracted the virus and have no immunity. Of course the individuals in these groups do not rea.....
    Document: To simulate the prevalence of antibodies in the general population the model is preconditioned with different proportions of the population in the Q S and Q R states. This is analogous to the proportion of people that are currently in quarantine who have either had the virus and developed some immunity, and the proportion of the population who have not contracted the virus and have no immunity. Of course the individuals in these groups do not really know their viral history, and hence would not know which state 8 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • antibody prevalence and general population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • antibody prevalence and International license: 1
    • antibody prevalence and viral history: 1
    • cc NC ND International license and general population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • cc NC ND International license and group individual: 1
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • different proportion and general population: 1, 2, 3, 4
    • different proportion and International license: 1, 2
    • general population and group individual: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • general population and immunity develop: 1
    • general population and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • general population and viral history: 1, 2, 3
    • general population and virus contract: 1, 2
    • group individual and International license: 1, 2, 3
    • immunity develop and International license: 1, 2
    • International license and viral history: 1